Objective: To determine the frequency of ocular symptoms in COVID 19 patients and its association with systemic symptoms in active COVID 19 patients.
Methods: This is a cross sectional observational study of laboratory confirmed COVID-19 patients who were admitted in isolation wards for a period from Dec 16, 2020 to Jan 15, 2021. A structured form was used to extract the data from electronic medical records. Data collected included sociodemographic characteristics, presenting symptoms, systemic signs and symptoms, ocular symptoms, past medical history, RT-PCR and chest radiographic findings.
Results: A total of 44 patients (30 (68.2%) males and 14 (31.82%) females) were admitted to the isolation wards during the study period. The mean age (+ SD) age was 55.75 + 14.53 with median range 57.50 (14-92). Age <30 years i.e. 4.5%, 30-50 i.e. 27.3% and >50 i.e. 68.2%.Ocular symptoms were present in 17 patients (38.6%).
We conclude from our study that Ocular symptoms were present in 17 patients (38.6%) out of 44 (Total number of patients) However, these symptoms were mild, had no fixed pattern of occurrence, neither associated with the severity of the systemic disease nor associated with any serious ocular outcome
Rowlatt J. The Chinese doctor who tried to warn others about coronavirus. BBC News [Internet]. 2020;(February). Available from: https://www.bbc.com/news/world-asia-china-51364382
Tsai SC, Lu CC, Bau DT, Chiu YJ, Yen YT, Hsu YM, et al. Approaches towards fighting the COVID-19 pandemic (Review). Int J Mol Med. 2021;47(1):3–22.
Zhou Y, Duan C, Zeng Y, Tong Y, Nie Y, Yang Y, et al. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients. Ophthalmology. 2020;127(7):982–3.
3.Sun S, Su W, Lin CQ, Li X, Yan H, Tian B, et al. COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology. Discov Med [Internet]. 2020;29(158):145–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33007190
4.Inomata T, Kitazawa K, Kuno T, Sung J, Nakamura M, Iwagami M, et al. Clinical and prodromal ocular symptoms in coronavirus disease: A systematic review and meta-analysis. Investig Ophthalmol Vis Sci. 2020; 61(10):16–7.
Amesty MA, Alió del Barrio JL, Alió JL. COVID-19 Disease and Ophthalmology: An Update. Ophthalmol Ther. 2020; 9(3):1–2.
Rousseau A, Fenolland JR, Labetoulle M. SARS-CoV-2, COVID-19 and the eye: An update on published data. J Fr Ophtalmol. 2020; 43(7):642–52.
Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d’Ettorre G, Mastroianni CM, et al. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020; 10(1):1–2.
Ma N, Li P, Wang X, Yu Y, Tan X, Chen P, et al. Ocular Manifestations and Clinical Characteristics of Children with Laboratory-Confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol. 2020; 138(10):1079–86.
Hu K, Patel J, Patel BC. Ophthalmic Manifestations Of Coronavirus (COVID-19). StatPearls [Internet]. 2020 ;(Cdc):1–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32310553
Hong N, Yu W, Xia J, Shen Y, Yap M, and Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020; 98(5):e649–55.